DNAJC25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.787000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.670200E-01
Normal-vs-Stage2
7.330800E-01
Normal-vs-Stage3
1.548550E-01
Normal-vs-Stage4
4.027800E-01
Stage1-vs-Stage2
3.294200E-01
Stage1-vs-Stage3
4.010100E-02
Stage1-vs-Stage4
7.339800E-01
Stage2-vs-Stage3
8.530300E-02
Stage2-vs-Stage4
6.673600E-01
Stage3-vs-Stage4
2.124000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.788800E-01
Normal-vs-AfricanAmerican
8.112400E-01
Normal-vs-Asian
6.480800E-01
Caucasian-vs-AfricanAmerican
3.918200E-01
Caucasian-vs-Asian
8.863600E-01
AfricanAmerican-vs-Asian
6.914400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.886000E-01
Normal-vs-Female
6.576200E-01
Male-vs-Female
6.399600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.774200E-01
Normal-vs-Age(41-60Yrs)
4.348800E-01
Normal-vs-Age(61-80Yrs)
8.189400E-01
Normal-vs-Age(81-100Yrs)
9.861400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.252400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.012200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.910400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.903810E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.040100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.355200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.132800E-01
Normal-vs-Daily Drinker
7.953400E-01
Normal-vs-Weekly Drinker
8.628200E-01
Normal-vs-Occasional Drinker
4.261800E-01
Normal-vs-Social Drinker
6.394200E-01
Non Drinker-vs-Daily Drinker
4.235400E-01
Non Drinker-vs-Weekly Drinker
6.008000E-01
Non Drinker-vs-Occasional Drinker
8.578200E-02
Non Drinker-vs-Social Drinker
2.680200E-01
Daily Drinker-vs-Weekly Drinker
7.641600E-01
Daily Drinker-vs-Occasional Drinker
6.285800E-01
Daily Drinker-vs-Social Drinker
4.795800E-01
Weekly Drinker-vs-Occasional Drinker
3.122600E-01
Weekly Drinker-vs-Social Drinker
3.720400E-01
Occasional Drinker-vs-Social Drinker
6.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.185000E-01
Normal-vs-Grade 2
7.276800E-01
Normal-vs-Grade 3
7.743000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.413400E-01
Grade 1-vs-Grade 3
2.213200E-01
Grade 1-vs-Grade 4
5.185000E-01
Grade 2-vs-Grade 3
3.811400E-01
Grade 2-vs-Grade 4
7.276800E-01
Grade 3-vs-Grade 4
7.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.113800E-01
Normal-vs-NonDiabetic
6.797200E-01
Diabetic-vs-NonDiabetic
1.327180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.340800E-01
Normal-vs-NoPancreatitis
7.274200E-01
Pancreatitis-vs-NoPancreatitis
3.129800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.380800E-01
Normal-vs-N1
7.310800E-01
N0-vs-N1
2.727600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.677800E-01
Normal-vs-TP53-NonMutant
7.040600E-01
TP53-Mutant-vs-TP53-NonMutant
2.452600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
